Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
Cellular Immunology
|
October 1, 1986
Evaluation of ricin A-chain immunotoxins directed against human T cells
O W Press, E S Vitetta, A G Farr, et al.
Bone Marrow Transplantation
|
June 12, 2002
The use of radioimmunoconjugates in stem cell transplantation
J M Pagel, D C Matthews, F R Appelbaum, et al.
Cancer Treatment and Research
|
January 1, 1997
The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies
D C Matthews, F R Appelbaum, O W Press, et al.
Current Opinion in Hematology
|
July 1, 1995
Targeted therapy for hematologic malignancies: has its promise been realized?
D C Matthews, F R Appelbaum, O W Press, et al.
Blood
|
August 15, 1992
Monoclonal antibody-based therapies of leukemia and lymphoma
M L Grossbard, O W Press, F R Appelbaum, et al.
Cancer Research
|
September 1, 1989
Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies
O W Press, A G Farr, K I Borroz, et al.
Bioconjugate Chemistry
|
May 29, 1999
Hemolytic activity of pH-responsive polymer-streptavidin bioconjugates
C A Lackey, N Murthy, O W Press, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2000
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells
P A Carpenter, S Pavlovic, J Y Tso, et al.
Blood
|
February 1, 1987
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas
O W Press, F Appelbaum, J A Ledbetter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
F Buchegger, J-P Mach, O W Press, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
Cellular Immunology
|
October 1, 1986
Evaluation of ricin A-chain immunotoxins directed against human T cells
O W Press, E S Vitetta, A G Farr, et al.
Bone Marrow Transplantation
|
June 12, 2002
The use of radioimmunoconjugates in stem cell transplantation
J M Pagel, D C Matthews, F R Appelbaum, et al.
Cancer Treatment and Research
|
January 1, 1997
The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies
D C Matthews, F R Appelbaum, O W Press, et al.
Current Opinion in Hematology
|
July 1, 1995
Targeted therapy for hematologic malignancies: has its promise been realized?
D C Matthews, F R Appelbaum, O W Press, et al.
Blood
|
August 15, 1992
Monoclonal antibody-based therapies of leukemia and lymphoma
M L Grossbard, O W Press, F R Appelbaum, et al.
Cancer Research
|
September 1, 1989
Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies
O W Press, A G Farr, K I Borroz, et al.
Bioconjugate Chemistry
|
May 29, 1999
Hemolytic activity of pH-responsive polymer-streptavidin bioconjugates
C A Lackey, N Murthy, O W Press, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2000
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells
P A Carpenter, S Pavlovic, J Y Tso, et al.
Blood
|
February 1, 1987
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas
O W Press, F Appelbaum, J A Ledbetter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
F Buchegger, J-P Mach, O W Press, et al.
Page
of 10